ADVOCACY

AMP's 4th Annual Molecular Pathology Economics Summit
August 16th, 2024
Omni Shoreham Hotel, Washington D.C.

 

2024 Summary

  • Identify barriers to appropriate reimbursement for molecular pathology procedures;
  • Examine the impact of these barriers on various stakeholders and patient access to care; and
  • Propose potential solutions and/or novel approaches to overcoming barriers to implement shared policy goals from participating stakeholders in oncology, infectious diseases, and inherited conditions.

Access the document below:

 

 

With representation from clinical laboratories, pharmaceutical companies, patient advocacy organizations, and diagnostic manufacturers, the ?rst session focused on stakeholders’ perspectives and approaches to the unique challenges associated with coding, coverage, and reimbursement of molecular diagnostics and their respective impacts on patient care. This discussion was followed by a presentation from a subject matter expert on the current legislative activities potentially in?uencing and affecting the economics of molecular pathology.  Attendees also participated in breakout sessions aimed at identifying practical and applicable solutions for a variety of economic challenges. Each group provided several proposed action items for stakeholders to implement in the coming years.  

 

Facilitator

 

Clifford Goodman, PhD, has 35 years of experience in such areas as health technology assessment, evidence-based health care, clinical practice guidelines, health economics, and studies pertaining to health care innovation, regulation, and payment.  He directs studies and projects for an international range of government agencies; pharmaceutical, biotechnology, and medical device companies; health care provider institutions; and professional, industry, and patient advocacy groups.  His recent work has involved such areas as chronic disease, infectious disease, cancer, rare diseases, diagnostic testing, gene therapy, pharmacogenomics, personalized medicine, biosimilars, value frameworks, value-based contracting, social determinants of health, and applications of real-world data.  Dr. Goodman is an internationally recognized health policy issues moderator and facilitator of expert panels, advisory boards, workshops, and focus groups. 

Dr. Goodman served as chair of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC, 2009-12) for the Centers for Medicare and Medicaid Services (CMS).  He served as president of the professional society, Health Technology Assessment international (HTAi, 2011-13), and is a Fellow of the American Institute for Medical and Biological Engineering.  In 2022, he received the David Banta Distinguished Career Award in Health Technology Assessment from HTAi.  He earned a PhD from The Wharton School of the University of Pennsylvania, a Master of Science from The Georgia Institute of Technology, and a Bachelor of Arts from Cornell University. 

After 27 years, including as Senior Vice President, Dr. Goodman recently retired from The Lewin Group and is an independent consultant in health care technology and policy.

Notify Me

If you would like to be notified as more information becomes available, please complete this form.

Summit Planning Committee

AMP Economic Affairs Committee Chair
Jay Patel, MD
ARUP Laboratories

AMP Economic Affairs Committee Economics Summit Planning Chair
Samuel K. Caughron, MD
MAWD Pathology Group, P.A.

AMP Economic Affairs Committee Vice Chair: Coverage Decisions Infectious Disease
Erin Graf, BS, PhD
Mayo Clinic

AMP Economic Affairs Committee Vice Chair: Coverage Decisions Genetics and Oncology
Eric Vail, MS, MD
Cedars-Sinai Medical Center

AMP Economic Affairs Committee Vice Chair: New Codes and Pricing
Victoria M. Pratt, PhD, FACMG
Agena Bioscience

AMP Economic Affairs Committee Member
Jeff Gagan, MD/PhD
National Cancer Institute

AMP Economic Affairs Committee Member
Lloyd Hutchinson, PhD
UMass Memorial Medical Center

AMP Economic Affairs Committee Member
Rina Kansal, MD
Blood Center of Wisconsin

AMP Economic Affairs Committee Member
Ester Stein, BS, MBA
Abbott

AMP Economic Affairs Committee Member
Heather E. Williams, MS, PhD
Cache DNA

Government Relations Consultants: Innovative Policy Solutions
Jennifer Leib, ScM, CGC

Megan Anderson Brooks, PhD

Lindsey Trischler, MPAP

 

 

Supporters

ChAMPion Level Supporters

                                            

 

Pioneer Level Supporter

For more information on becoming an Industry Partner for this event please contact, Laurie Menser.

Corporate Partners